Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement
Aine Hurley,
Philip George,
Gemma Reynolds,
Adam Stewart,
Hang Quach,
Nicole O'Leary,
Zoe McQuilten,
Andrea S. Henden,
Lynette Chee,
Chan Y. Cheah,
Olivia Bupha‐Intr,
Emily Blyth,
Ben Teh,
Monica Slavin,
Michael Dickinson,
Robert Weinkove Internal Medicine Journal
· Wiley
· 2026-10-01
· DOI: 10.1111/imj.70644
Аннотация
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against c luster of differentiation 19 ( CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt. Recipients of CAR T‐cells can present in various clinical settings, and few trials have prospectively assessed prevention and management of infection in this group. This position statement provides Australian and New Zealand clinicians with a rational approach to preventing, investigating and managing infections after CD19‐directed CAR T‐cell therapy for lymphoma.
Aine Hurley, Philip George, Gemma Reynolds, Adam Stewart, Hang Quach, Nicole O'Leary et al. Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement. // Internal Medicine Journal. – 2026. – DOI: 10.1111/imj.70644. – URL: https://onlinelibrary.wiley.com/doi/10.1111/imj.70644?af=R
Aine Hurley, Philip George, Gemma Reynolds, Adam Stewart, Hang Quach, Nicole O'Leary, Zoe McQuilten, Andrea S. Henden, Lynette Chee, Chan Y. Cheah, Olivia Bupha‐Intr, Emily Blyth, Ben Teh, Monica Slavin, Michael Dickinson, & Robert Weinkove (2026). Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement. Internal Medicine Journal. https://doi.org/10.1111/imj.70644
Aine Hurley, et al. “Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement.” Internal Medicine Journal, 2026. doi:10.1111/imj.70644.
@article{Hurley2026,
title = {Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement},
author = {Hurley, Aine and George, Philip and Reynolds, Gemma and Stewart, Adam and Quach, Hang and O'Leary, Nicole and McQuilten, Zoe and Henden, Andrea S. and Chee, Lynette and Cheah, Chan Y. and Bupha‐Intr, Olivia and Blyth, Emily and Teh, Ben and Slavin, Monica and Dickinson, Michael and Weinkove, Robert},
journal = {Internal Medicine Journal},
year = {2026},
doi = {10.1111/imj.70644},
url = {https://onlinelibrary.wiley.com/doi/10.1111/imj.70644?af=R}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...